THURSDAY, Feb. 26 (HealthDay News) — Sanofi-Aventis’s Apidra (insulin glulisine) Solostar injection pen has been approved to treat diabetes, the company said Thursday in a news release.
The disposable pen with rapid-acting insulin was approved for adults with type 2 diabetes and for children four years and older with type 1 diabetes.
The device requires lower injection force than competing products, the drug maker said.
More information
The FDA has additional information about Apidra, a drug first approved in 2004.
— Scott Roberts
Last Updated: Feb. 26, 2009
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Related Links:
Comments (0)